In the present study we examined the intracellular pathways that link
hypoxia to activation of c-fos gene expression. Experiments were performed on rat pheocromocytoma-12 (PC-12) cells. c-fos
mRNA and promoter activities were analyzed by RT-PCR and reporter gene assays, respectively.
BAPTA, a Ca(2+)
chelator, inhibited c-fos
mRNA and promoter activation by
hypoxia.
Nitrendipine, an L-type Ca(2+)-channel blocker, abolished, whereas
BAY K 8644, an L-type channel agonist, enhanced c-fos activation by
hypoxia. Ca(2+) currents were augmented reversibly by
hypoxia, suggesting that Ca(2+) influx mediated by L-type Ca(2+) channels is essential for c-fos activation by
hypoxia. We next determined downstream pathways activated by intracellular Ca(2+) concentration. Immunoblot analysis revealed Ca(2+)/
calmodulin-dependent
kinase II (
CaMKII)
protein in PC-12 cells and revealed that
hypoxia increased the
enzyme activity.
KN-93, a CaMK inhibitor, blocked
CaMKII activation and c-fos promoter stimulation by
hypoxia. Ectopic expression of an active mutant of
CaMKII (pCaMKII290) stimulated c-fos promoter activity under normoxia.
Hypoxia increased phosphorylation of CREB at the
serine residue 133 (Ser-133), and
KN-93 attenuated this effect. Point mutations at the Ca(2+)/cAMP-responsive cis-
element (Ca/CRE) attenuated, whereas point mutations in the serum-responsive cis-
element (SRE) abolished transcriptional activation of c-fos by
hypoxia. These results demonstrate that c-fos activation by
hypoxia involves CaMK activation and CREB phosphorylation at Ser-133 and requires Ca/CRE and SRE. These observations demonstrate that Ca(2+)-dependent signaling pathways play a crucial role in induction of c-fos gene expression, which may underlie long-term adaptive responses to
hypoxia.